4.5 Article

Prediction of Schizophrenia Diagnosis by Integration of Genetically Correlated Conditions and Traits

Journal

JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 13, Issue 4, Pages 532-540

Publisher

SPRINGER
DOI: 10.1007/s11481-018-9811-8

Keywords

Polygenic risk score; Risk prediction; Schizophrenia; Deep neural network

Funding

  1. NIH [MH101054]
  2. NIMH [R01 MH077139, R01 MH095034]
  3. Stanley Center for Psychiatric Research
  4. Sylvan Herman Foundation
  5. Friedman Brain Institute at the Mount Sinai School of Medicine
  6. Karolinska Institutet
  7. Swedish Research Council
  8. Swedish County Council
  9. Soderstrom Konigska Foundation
  10. Netherlands Scientific Organization [NWO 645-000-003]
  11. National Institute of Mental Health [N01 MH900001, MH074027]
  12. Eli Lilly and Company
  13. Karolinska University Hospital
  14. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121325, U54GM104944] Funding Source: NIH RePORTER
  15. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101054, R01MH095034] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Schizophrenia is genetically heterogeneous and comorbid with many conditions. In this study, we explored polygenic scores (PGSs) from genetically related conditions and traits to predict schizophrenia diagnosis using both logistic regression and deep neural network (DNN) models. We used the combined Molecular Genetics of Schizophrenia and Swedish Schizophrenia Case Control Study (MGS+SSCCS) data for training and testing the models, and used the Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) data as independent validation. We screened 28 conditions and traits comorbid with schizophrenia to identify traits as potential predictors and used LASSO regression to select predictors for model construction. We investigated how PGS calculation influenced model performance. We found that the inclusion of comorbid traits improved model performance and PGSs calculated from two traits were more generalizable in independent validation. With a DNN model using 19 PGS predictors, we accomplished a prediction accuracy of 0.813 and an AUC of 0.905 in the MGS+SSCCS data. When this model was validated with the CATIE data, it achieved an accuracy of 0.721 and AUC of 0.747. Our results indicate that PGSs alone may not be sufficient to predict schizophrenia accurately and the inclusion of behavioral and clinical data may be necessary for more accurate prediction model.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available